Počet záznamov: 1
Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension
Názov Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension Autor Kružliak Peter 1982- Spoluautori Kováčová Gabriela Pecháňová Oľga 1962- SAVNOPAT - Ústav normálnej a patologickej fyziológie SAV SCOPUS ORCID Zdroj.dok. Angiogenesis. Vol. 16, no. 2 (2013), p. 289-295 Jazyk dok. eng - angličtina Krajina NL - Holandsko Poznámky FNUSA-ICRC (No.CZ.1.05/1.1.00/02.0123), ITMS 26240120020, APVV-0742-10, VEGA 2/0190/11 Druh dok. rozpis článkov z periodík (rbx) Ohlasy HEYLMAN, C. - SOBRINO, A. - SHIRURE, V.S. - HUGHES, C.C.W. - GEORGE, S.C. A strategy for integrating essential three-dimensional microphysiological systems of human organs for realistic anticancer drug screening. In EXPERIMENTAL BIOLOGY AND MEDICINE. ISSN 1535-3702, SEP 2014, vol. 239, no. 9, p. 1240-1254. LAMBRECHTS, D. - MOISSE, M. - DELMAR, P. - MILES, D.W. - LEIGHL, N. - ESCUDIER, B. - VAN CUTSEM, E. - BANSAL, A.T. - CARMELIET, P. - SCHERER, S.J. - DE HAAS, S. - PALLAUD, C. Genetic markers of bevacizumab-induced hypertension. In ANGIOGENESIS. ISSN 0969-6970, JUL 2014, vol. 17, no. 3, p. 685-694. SMALL, H.Y. - MONTEZANO, A.C. - RIOS, F.J. - SAVOIA, C. - TOUYZ, R.M. Hypertension Due to Antiangiogenic Cancer Therapy With Vascular Endothelial Growth Factor Inhibitors: Understanding and Managing a New Syndrome. In CANADIAN JOURNAL OF CARDIOLOGY. ISSN 0828-282X, MAY 2014, vol. 30, no. 5, p. 534-543. GUPTA, D.- YADAV, N.- EVANS, F.- STEINGART, R.M. Chemotherapy-Induced Cardiomyopathy in the Elderly. In CURRENT CARDIOVASCULAR RISK REPORTS,2014, vol. 8, no.12, p. 1-8. LANKHORST, S. - KAPPERS, M.H.W. - VAN ESCH, J.H.M. - SMEDTS, F.M.M. - SLEIJFER, S. - MATHIJSSEN, R.H.J. - BAELDE, H.J. - DANSER, A.H.J. - VAN DEN MEIRACKER, A.H. Treatment of Hypertension and Renal Injury Induced by the Angiogenesis Inhibitor Sunitinib Preclinical Study. In HYPERTENSION. ISSN 0194-911X, DEC 2014, vol. 64, no. 6, p. 1282-U260. RICCA, A.M. - MORSHEDI, R.G. - WIROSTKO, B.M. High Intraocular Pressure Following Anti-Vascular Endothelial Growth Factor Therapy: Proposed Pathophysiology due to Altered Nitric Oxide Metabolism. In JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS. ISSN 1080-7683, FEB 1 2015, vol. 31, no. 1, p. 2-10. LANKHORST, S. - SALEH, L. - DANSER, A.H.J. - VAN DEN MEIRACKER, A.H. Etiology of angiogenesis inhibition-related hypertension. In CURRENT OPINION IN PHARMACOLOGY. ISSN 1471-4892, APR 2015, vol. 21, p. 7-13. KASSEL, L.E. - ODUM, L.E. Our Own Worst Enemy: Pharmacologic Mechanisms of Hypertension. In ADVANCES IN CHRONIC KIDNEY DISEASE. ISSN 1548-5595, MAY 2015, vol. 22, no. 3, p. 245-252. LEÓN-MATEOS, L. - MOSQUERA, J. - ANTÓN APARICIO, L. Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors. In REDOX BIOLOGY, 2015, vol. 6, art. no. 356, pp. 421-425. LUIZON, M.R. - SANDRIM, V.C. Hypertension and vascular endothelial growth factors (Book Chapter). In Pathophysiology and Pharmacotherapy of Cardiovascular Disease, 2015, pp. 695-707. DERAY, G. - JANUS, N. - ALOY, B. - LAUNAY-VACHER, V. Renovascular effects of antiangiogenic drugs. In BULLETIN DU CANCER. ISSN 0007-4551, JUL-AUG 2016, vol. 103, no. 7-8, p. 662-666. MORSHEDI, R.G. - RICCA, A.M. - WIROSTKO, B.M. Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide. In JOURNAL OF GLAUCOMA. ISSN 1057-0829, MAR 2016, vol. 25, no. 3, p. 291-300. FU, Z.X. - XIE, Y. - DAI, Z.T. The association between intron 4 polymorphism of endothelial nitric oxide synthase gene (eNOS) and osteonecrosis of femoral head: a meta-analysis. In INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE. ISSN 1940-5901, 2016, vol. 9, no. 3, p. 6030-6037. JURCUT, R. - POPARA-VOICA, A.M. - SERBANESCU, G.L. - CROITORU, A. - GINGHINA, O. - IONITA, O. - ANGHEL, R. - GINGHINA, C. CARDIOVASCULAR EFFECTS OF ANTIANGIOGENIC ONCOLOGICAL THERAPIES. THE FINE BALANCE OF BENEFITS AND RISKS. In FARMACIA. ISSN 0014-8237, JAN-FEB 2016, vol. 64, no. 1, p. 13-23. CAMERON, A.C. - TOUYZ, R.M. - LANG, N.N.A.N. Vascular Complications of Cancer Chemotherapy. In CANADIAN JOURNAL OF CARDIOLOGY. ISSN 0828-282X, JUL 2016, vol. 32, no. 7, p. 852-862. CAMERON, A.C. - LANG, N.N. - TOUYZ, R.M. Cardiovascular Complications From Cancer Therapy: Hypertension-Focus on Vascular Endothelial Growth Factor Inhibitors.(Book Chapter). In Clinical Cardio-oncology, 2016, pp. 185-211. KENIGSBERG, B. - CAMPIA, U. - BARAC, A. Cardiovascular side effects of cancer treatments. In CLINICAL PHARMACIST, 2016, vol.8, no. 9. BRINDA, B.J. - VIGANEGO, F. - VO, T. - DOLAN, D. - FRADLEY, M.G. Anti-VEGF-induced hypertension: A review of pathophysiology and treatment options. In CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2016, vol. 18, no. 5, art. no. 66. SUKMANSKY, O. I. - REUTOV, V. P. Gasotransmitters: Physiological Role and Involvement in the Pathogenesis of the Diseases. In Uspekhi Fiziologicheskikh Nauk. ISSN 0301-1798, JUL-SEP 2016, vol. 47, no. 3, p. 30-58. CHAKRABORTY, S. - AIN, R. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling. In JOURNAL OF BIOLOGICAL CHEMISTRY. ISSN 0021-9258, APR 21 2017, vol. 292, no. 16, p. 6600-6620. CARTER, J.J. - FRETWELL, L.V. - WOOLARD, J. Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats. In FASEB JOURNAL. ISSN 0892-6638, MAR 2017, vol. 31, no. 3, p. 1193-1203. MUTO, S. - TAKAGI, H. - OWADA, Y. - INOUE, T. - WATANABE, Y. - YAMAURA, T. - FUKUHARA, M. - OKABE, N. - MATSUMURA, Y. - HASEGAWA, T. - OSUGI, J. - HOSHINO, M. - HIGUCHI, M. - SHIO, Y. - SUZUKI, H. Serum Nitric Oxide as a Predictive Biomarker for Bevacizumab in Non-small Cell Lung Cancer Patients. In ANTICANCER RESEARCH. ISSN 0250-7005, JUN 2017, vol. 37, no. 6, p. 3169-3174. WILK, M. - SZMIT, S. Cardiovascular complications of antiangiogenic therapy in ovarian cancer patients. In ONCOLOGY IN CLINICAL PRACTICE. ISSN 2450-1654, 2017, vol. 13, no. 2, p. 49-56. TINNING, A.R. - BENGTSEN, C. - JENSEN, N.V. - BASTHOLT, L. - JENSEN, B.L. - MADSEN, K. Pazopanib-Induced Hypertension in Patients With Renal Cell Carcinoma Is Associated With Low Urine Excretion of NO Metabolites. In HYPERTENSION. ISSN 0194-911X, MAR 2018, vol. 71, no. 3, p. 473-480. LI, M.G. - KROETZ, D.L. Bevacizumab-induced hypertension: Clinical presentation and molecular understanding. In PHARMACOLOGY & THERAPEUTICS. ISSN 0163-7258, FEB 2018, vol. 182, p. 152-160. KALAITZIDIS, R.G. - ELISAF, M.S. Uncontrolled Hypertension and Oncology: Clinical Tips. In CURRENT VASCULAR PHARMACOLOGY. ISSN 1570-1611, 2018, vol. 16, no. 1, p. 23-29. CALETTI, S. - PAINI, A. - COSCHIGNANO, M.A. - DE CIUCEIS, C. - NARDIN, M. - ZULLI, R. - MUIESAN, M.L. - SALVETTI, M. - RIZZONI, D. Management of VEGF-Targeted Therapy-Induced Hypertension. In CURRENT HYPERTENSION REPORTS. ISSN 1522-6417, AUG 2018, vol. 20, no. 8. MANOLIS, A.A. - MANOLIS, T.A. - MIKHAILIDIS, D.P. - MANOLIS, A.S. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2. In EXPERT OPINION ON DRUG SAFETY. ISSN 1474-0338, 2018, vol. 17, no. 9, p. 893-915. MILLING, R.V. - GRIMM, D. - KRUGER, M. - GROSSE, J. - KOPP, S. - BAUER, J. - INFANGER, M. - WEHLAND, M. Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. ISSN 1422-0067, OCT 2018, vol. 19, no. 10. SOLIMAN, W.M. - ABDELLATIF, K.R.A. - KNAUS, E.E. Design, synthesis, biological evaluation, and nitric-oxide release studies of a novel series of celecoxib prodrugs possessing a nitric-oxide donor moiety. In BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES. ISSN 1984-8250, 2018, vol. 54, no. 4. WILSON, A. - MENON, V. - KHAN, Z. - ALAM, A. - LITOVCHICK, L. - YAKOVLEV, V. Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation. In REDOX BIOLOGY. ISSN 2213-2317, JUN 2019, vol. 24. TSANG, V.H.M. Management of treatment-related toxicities in advanced medullary thyroid cancer. In CURRENT OPINION IN ONCOLOGY. ISSN 1040-8746, MAY 2019, vol. 31, no. 3, p. 236-242. VERSMISSEN, J. - COLAFELLA, K.M.M. - KOOLEN, S.L.W. - DANSER, A.H.J. Vascular Cardio-Oncology: Vascular Endothelial Growth Factor inhibitors and hypertension. In CARDIOVASCULAR RESEARCH. ISSN 0008-6363, APR 15 2019, vol. 115, no. 5, p. 904-914. PUCCI, G. - MILAN, A. - PAINI, A. - SALVETTI, M. - CERASARI, A. - VAUDO, G. Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors. In EXPERT OPINION ON BIOLOGICAL THERAPY. ISSN 1471-2598, MAY 4 2019, vol. 19, no. 5, p. 433-442. GAO, Y.F. - ZHOU, S. - XU, Y. - SHENG, S. - QIAN, S.Y. - HUO, X.W. Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. In NITRIC OXIDE-BIOLOGY AND CHEMISTRY. ISSN 1089-8603, FEB 1 2019, vol. 83, p. 33-39. DALBENI, A. - CICCARESE, C. - BEVILACQUA, M. - BENATI, M. - CAIMMI, C. - CERRITO, L. - FAMA, F. - IACOVELLI, R. - MANTOVANI, A. - MENEGUZZI, F.M.A. - MINUZ, P. - MONTAGNANA, M. - ORSOLINI, G. - ROSSINI, M. - TORTORA, G. - VIAPIANA, O. - FAVA, C. Effects of Antiangiogenetic Drugs on Microcirculation and Macrocirculation in Patients with Advanced-Stage Renal Cancer. In CANCERS. ISSN 2072-6694, JAN 2019, vol. 11, no. 1. GUHA, A. - ARMANIOUS, M. - FRADLEY, M.G. Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicitie. In TRENDS IN CARDIOVASCULAR MEDICINE. ISSN 1050-1738, JAN 2019, vol. 29, no. 1, p. 29-39. NOVO, G. - DI LISI, D. - BRONTE, E. - FIUZA, M. - PINTO, F.J. Cardiovascular Damage Induced by Anti-VEGF Therapy. In CARDIOVASCULAR COMPLICATIONS IN CANCER THERAPY. 2019, p. 33-44. LV, H. - LIU, B. - QIN, Y.W. Isosorbide mononitrate promotes angiogenesis in embryonic development of zebrafish. In GENETICS AND MOLECULAR BIOLOGY. ISSN 1415-4757, 2020, vol. 43, no. 3, art. no. e20190233. NEVES, K.B. - MONTEZANO, A.C. - LANG, N.N.N. - TOUYZ, R.M. Vascular toxicity associated with anti-angiogenic drugs. In CLINICAL SCIENCE. ISSN 0143-5221, SEP 2020, vol. 134, no. 18, p. 2503-2520. ESSA, H. - DOBSON, R. - WRIGHT, D. - LIP, G.Y.H. Hypertension management in cardio-oncology. In JOURNAL OF HUMAN HYPERTENSION. ISSN 0950-9240, OCT 2020, vol. 34, no. 10, p. 673-681. BIEL, V. - NOVAK, J. - RIMALOVA, V. - TOMANDLOVA, M. - TOMANDL, J. - SPAC, J. - SOUCEK, M. Levels of endothelial substances in patients with newly identified hypertension compared with healthy controls. In BIOMEDICAL PAPERS-OLOMOUC. ISSN 1213-8118, DEC 2021, vol. 165, no. 4, p. 395-401. LIU, M.Y. - GAO, Q. - SUN, C.X. - LIU, B. - LIU, X. - ZHOU, Q.L. - ZHENG, X.C. - XU, P. - LIU, B. Effects of dietary tea tree oil on the growth, physiological and non-specific immunity response in the giant freshwater prawn (Macrobrachium rosenbergii) under high ammonia stress. In FISH & SHELLFISH IMMUNOLOGY. ISSN 1050-4648, JAN 2022, vol. 120, p. 458-469. ANGEL-KORMAN, Avital - RAPOPORT, Vladimir - LEIBA, Adi. The Relationship Between Hypertension and Cancer. In ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, vol. 24, no. 3, pp. 165-169. ISSN 1565-1088. HERRMANN, Sandra M.S. - DOBBIN, Stephen J.H. - HERRMANN, Joerg - TOUYZ, Rhian M. - LANG, Ninian N. Hypertension and renal disease during anti-cancer therapies. In Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease, 2022-01-01, pp. 185-199. Dostupné na: https://doi.org/10.1016/B978-0-323-68135-3.00029-5. LANERI, F. - LICCIARDELLO, N. - SUZUKI, Y. - GRAZIANO, A.C.E. - SODANO, F. - FRAIX, A. - SORTINO, S. A Supramolecular Nanoassembly of Lenvatinib and a Green Light-Activatable NO Releaser for Combined Chemo-Phototherapy. In PHARMACEUTICS. JAN 2023, vol. 15, no. 1. WANG, L.H. - WEHLAND, M. - WISE, P.M. - INFANGER, M. - GRIMM, D. - KREISSL, M.C. Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect. In INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. FEB 2023, vol. 24, no. 3. SU, J.Y. - LU, J.H. - ZHANG, J.L. - WANG, M.L. - YAN, J. - LIN, S.Y. A meta-analysis of the efficacy and toxicity of tyrosine kinase inhibitors in treating patients with different types of thyroid cancer: how to choose drugs appropriately?. In CURRENT OPINION IN ONCOLOGY. ISSN 1040-8746, MAR 2023, vol. 35, no. 2, p. 132-144. SU, J.Y. - NI, C. - WU, Y.Q. - ZHANG, J.L. - CAI, Z.L. - LU, J.H. - LIN, S.Y. - WANG, J. Comparative efficacy and safety of cabozantinib for malignant tumors: a systematic review and meta-analysis. In EXPERT REVIEW OF ANTICANCER THERAPY. ISSN 1473-7140, MAY 3 2024, vol. 24, no. 5, p. 293-302. TRAVERS, Richard J. - STEPANIAN, Alec - JAFFE, Iris. Endothelium as a Source of Cardiovascular Toxicity from Antitumor Kinase Inhibitors. In Arteriosclerosis, Thrombosis, and Vascular Biology, 2024-01-01, pp. ISSN 10795642. Dostupné na: https://doi.org/10.1161/ATVBAHA.124.319864. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2013 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.1007/s10456-012-9327-4 
článok
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2013 2012 3.972 Q1 2.022 Q1
Počet záznamov: 1